Search

Your search keyword '"Riemekasten G"' showing total 195 results

Search Constraints

Start Over You searched for: "Riemekasten G" Remove constraint "Riemekasten G" Database OpenAIRE Remove constraint Database: OpenAIRE
195 results on '"Riemekasten G"'

Search Results

2. Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research

3. Fighting Post-COVID and ME/CFS – development of curative therapies

4. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis

5. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

6. Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database

7. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

8. Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database

9. 30-jährige Patientin mit plötzlich aufgetretenen hämorrhagischen Nekrosen beider Beine

10. Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study

11. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

13. Update of EULAR recommendations for the treatment of systemic sclerosis

14. Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)

15. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study

16. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

17. Receptor expression of angiotensin type 1 and 2 are decreased and correlate with serological titers of NT-proBNP and the FVC/DLCO ratio in patients with systemic sclerosis and pulmonary arterial hypertension

18. Decreased C5aR1 autoantibodies correlate with higher relapse rates in ANCA-associated vasculitis

19. Schmerzen? 'Wie ein Tiger, der mich von innen zerfrisst!'

20. A late onset of systemic sclerosis correlates with a more rapidly progressing clinical phenotype in lcSSc patients – Data of the German Network for Systemic Sclerosis

21. Anti-beta-adrenoceptor autoantibodies are elevated in systemic sclerosis

22. Autoantibodies targeting CXCR3 and CXCR4 affect the expression of their cognate receptors in lung tissue of the ApoE knockout mouse model

23. Significance of pulmonary involvement in systemic sclerosis (SSc) – data from the German SSc-network

24. Role of anti-alpha-adrenoceptor autoantibodies and leukocytic alpha-adrenoceptors in primary Raynaud’s phenomenon

25. A new score to predict digital ulcers combining clinical data, imaging and patient history in systemic sclerosis

26. Patterns of 31 new autoantibodies against G-protein-coupled receptors and growth factors in systemic sclerosis can be described by latent factors

27. Adhesion of cytomegalovirus-specific CD8+ T cells in systemic sclerosis

28. SSC in older age: Frequent and with a different phenotype. Data of the German Network for Systemic Sclerosis

29. Increased expression of the costimulatory c-type lectin (CD161) on circulating PR3-specific CD8+ and CD4+CD8+ T-cells in GPA

30. Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort

31. Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosis

32. IDENTIFICATION OF FOUR NEW SHARED SUSCEPTIBILITY GENES IN SYSTEMIC SCLEROSIS AND CROHN¿S DISEASE THROUGH A CROSS-DISEASE META-GWAS

33. A CROSS-DISEASE META-GWAS IDENTIFIES IRF1, STAT3 AND ZBTB9-BAK1 AS NEW SHARED SUSCEPTIBILITY LOCI IN SYSTEMIC SCLEROSIS AND CROHN¿S DISEASE

34. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

35. What have multicentre registries across the world taught us about the disease features of systemic sclerosis?

36. Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study

37. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database

38. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility

39. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis. a 10-year longitudinal study from the EUSTAR database

40. Digital ulcers predict a worse disease course in patients with systemic sclerosis

41. Autoantibodies targeting complement receptors 3a and 5a are decreased in ANCA-associated vasculitis

42. Different transcriptome profiles of CD4+CD8+ double-positive T-cells between granulomatosis with polyangiitis and healthy controls

43. 31-jährige Patientin mit Verdacht auf Takayasu Arteriitis

44. A MIF PROMOTER POLYMORPHISM IS ASSOCIATED WITH THE SUSCEPTIBILITY TO PULMONARY ARTERIAL HYPERTENSION IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS PATIENTS

45. Diffusing capacity and clinical characteristics of patients with systemic sclerosis – data from the german network for systemic sclerosis

46. Mapping and predicting mortality from systemic sclerosis

47. Update of EULAR recommendations for the treatment of systemic sclerosis

50. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database

Catalog

Books, media, physical & digital resources